Matches in SemOpenAlex for { <https://semopenalex.org/work/W1960988894> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W1960988894 endingPage "20" @default.
- W1960988894 startingPage "13" @default.
- W1960988894 abstract "The kidneys play an essential role in PRRT. The infusion of amino acids could reduce uptake in the kidney of radiolabelled peptides. The purpose of this study was to determine the extent of kidney damage post PRRT.53 patients, with disseminated neuroendocrine tumours (NET), received 3-5 cycles of up to a maximum 7.4 GBq/m2 calculated dose of 90Y-DOTATATE (n = 25) and 90Y/177Lu-DOTATATE (n = 28). Creatinine levels were measured and glomerular filtration rates (GFR) were calculated. A mixed amino acid infusion was used for nephroprotection.Patients treated with 90Y-DOTATATE had a mean creatinine level of 0.77 ± 0.19 mg/dL and a mean GFR (mL/min/1.73 m2) of 103.6 ± 30.8. Patients treated with 90Y/177Lu-DOTATATE had a mean creatinine level of 0.92 ± 0.33 mg/dL and a mean GFR of 84.7 ± 26.3. In the follow up, among patients treated with 90Y-DOTATATE and 90Y/177Lu-DOTATATE, the mean GFR level at 12 months was 101.2 ± 31.3 v. 83.9 ± 25.2, at 24 months 80.2 ± 32.7 v. 77.2 ± 31.1, at 36 months 78.9 ± 42.1 v. 67.5 ± 9.7, and 48 months 59.7 ± 15.2 v. 72.6 ± 11.2. The mean yearly decrease in GFR was 4.5 mL in all treated patients; for patients treated with 90Y-DOTATATE and 90Y/177Lu-DOTATATE it was 6.8 v. 3.0, respectively.90Y/177Lu-DOTATATE treatment induced statistically significantly less change in kidney function compared to 90Y-DOTATATE." @default.
- W1960988894 created "2016-06-24" @default.
- W1960988894 creator A5001567130 @default.
- W1960988894 creator A5005327464 @default.
- W1960988894 creator A5007773763 @default.
- W1960988894 creator A5008837385 @default.
- W1960988894 creator A5010530541 @default.
- W1960988894 creator A5062377015 @default.
- W1960988894 date "2013-01-01" @default.
- W1960988894 modified "2023-09-23" @default.
- W1960988894 title "Nephrotoxicity after PRRT - still a serious clinical problem? Renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATATE and 90Y/177Lu-DOTATATE." @default.
- W1960988894 cites W1933764379 @default.
- W1960988894 cites W1968852634 @default.
- W1960988894 cites W1977804080 @default.
- W1960988894 cites W1984882652 @default.
- W1960988894 cites W1989552774 @default.
- W1960988894 cites W2009629472 @default.
- W1960988894 cites W2010485212 @default.
- W1960988894 cites W2010599483 @default.
- W1960988894 cites W2020347413 @default.
- W1960988894 cites W2027511464 @default.
- W1960988894 cites W2027676394 @default.
- W1960988894 cites W2030819789 @default.
- W1960988894 cites W2055864845 @default.
- W1960988894 cites W2058383136 @default.
- W1960988894 cites W2072733111 @default.
- W1960988894 cites W2097512974 @default.
- W1960988894 cites W2098934193 @default.
- W1960988894 cites W2108613323 @default.
- W1960988894 cites W2123859260 @default.
- W1960988894 cites W2274106750 @default.
- W1960988894 cites W2321986725 @default.
- W1960988894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23450442" @default.
- W1960988894 hasPublicationYear "2013" @default.
- W1960988894 type Work @default.
- W1960988894 sameAs 1960988894 @default.
- W1960988894 citedByCount "6" @default.
- W1960988894 countsByYear W19609888942013 @default.
- W1960988894 countsByYear W19609888942017 @default.
- W1960988894 countsByYear W19609888942018 @default.
- W1960988894 countsByYear W19609888942023 @default.
- W1960988894 crossrefType "journal-article" @default.
- W1960988894 hasAuthorship W1960988894A5001567130 @default.
- W1960988894 hasAuthorship W1960988894A5005327464 @default.
- W1960988894 hasAuthorship W1960988894A5007773763 @default.
- W1960988894 hasAuthorship W1960988894A5008837385 @default.
- W1960988894 hasAuthorship W1960988894A5010530541 @default.
- W1960988894 hasAuthorship W1960988894A5062377015 @default.
- W1960988894 hasConcept C126189478 @default.
- W1960988894 hasConcept C126322002 @default.
- W1960988894 hasConcept C126894567 @default.
- W1960988894 hasConcept C134018914 @default.
- W1960988894 hasConcept C159641895 @default.
- W1960988894 hasConcept C2780091579 @default.
- W1960988894 hasConcept C2780306776 @default.
- W1960988894 hasConcept C29730261 @default.
- W1960988894 hasConcept C2993559085 @default.
- W1960988894 hasConcept C71924100 @default.
- W1960988894 hasConceptScore W1960988894C126189478 @default.
- W1960988894 hasConceptScore W1960988894C126322002 @default.
- W1960988894 hasConceptScore W1960988894C126894567 @default.
- W1960988894 hasConceptScore W1960988894C134018914 @default.
- W1960988894 hasConceptScore W1960988894C159641895 @default.
- W1960988894 hasConceptScore W1960988894C2780091579 @default.
- W1960988894 hasConceptScore W1960988894C2780306776 @default.
- W1960988894 hasConceptScore W1960988894C29730261 @default.
- W1960988894 hasConceptScore W1960988894C2993559085 @default.
- W1960988894 hasConceptScore W1960988894C71924100 @default.
- W1960988894 hasIssue "1" @default.
- W1960988894 hasLocation W19609888941 @default.
- W1960988894 hasOpenAccess W1960988894 @default.
- W1960988894 hasPrimaryLocation W19609888941 @default.
- W1960988894 hasRelatedWork W1976143010 @default.
- W1960988894 hasRelatedWork W1997125233 @default.
- W1960988894 hasRelatedWork W2076032188 @default.
- W1960988894 hasRelatedWork W2093874596 @default.
- W1960988894 hasRelatedWork W2130929552 @default.
- W1960988894 hasRelatedWork W2168841446 @default.
- W1960988894 hasRelatedWork W2408829444 @default.
- W1960988894 hasRelatedWork W2409951727 @default.
- W1960988894 hasRelatedWork W2416878559 @default.
- W1960988894 hasRelatedWork W2566477261 @default.
- W1960988894 hasVolume "64" @default.
- W1960988894 isParatext "false" @default.
- W1960988894 isRetracted "false" @default.
- W1960988894 magId "1960988894" @default.
- W1960988894 workType "article" @default.